Status:
COMPLETED
Medical Compression in Patients With Chronic Wound and Peripheral Arterial Disease
Lead Sponsor:
University Hospital, Montpellier
Collaborating Sponsors:
Société Française de Médecine Vasculaire (SFMV)
Conditions:
Peripheral Arterial Disease
Chronic Wound of the Lower Limb (Leg Ulcer or Foot Ulcer)
Eligibility:
All Genders
18+ years
Brief Summary
Real-life practice survey of vascular specialist in France caring for patients with chronic wound for which compression treatment would be indicated and arterial disease of the lower limbs
Detailed Description
The leg chronic wound is a frequent and recurrent chronic disease of the lower limb, causing an impairment in the quality of life of patients and at a significant cost to society. Medical compression ...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Patient taken care of by a vascular specialist
- Practicing, in a hospital or not or in a healing center,
- Caring for patients with leg ulcers requiring the indication of compression treatment,
- Can include consecutive patients at each consultation over the entire duration of the study or at a pre-established rate of at least half a day per week
- Patient with a chronic leg wound (leg ulcer and foot ulcer), defined as a chronic leg wound that does not spontaneously tend to heal after 6 weeks in the case of a first episode or 2 weeks in the case of recurrenceo In principle justifying a compression treatment, o And concomitantly presenting with PAD, retained by the investigator according to clinical and hemodynamic criteria that he will describe.
- Exclusion criteria:
- Patient not giving his consent for collection of study data
- Patient with a life expectancy of less than 6 months.
- Patients for whom telephone follow-up is impossible (no contact possible with the patient, family and friends, IDE and the doctor)
- Patient presenting:
- A leg wound that is not chronic, or does not validate the ulcer criteria;
- An ulcer not located on the leg, in particular trophic disorders above the knee;
- Necrotic angiodermatitis
- Systemic sclerosis
- An infected ulcer (not temporary)
- An arterial ulcer, with PAD at the critical ischemia stage (ICC 2020 consensus), ABI\<0.6, systolic ankle pression \<60mmHg, systolic toe pression\<30mmHg, TCPO2\<20mmHg, bypass of lower limbs
- Patients for whom compression is not an option, regardless of arteriopathy, especially in cases of:
- Allergy or intolerance to compression equipment
- Practical or organizational installation difficulties
- Morphotype difficult to fit (due to obesity, cachexia, trauma, dermatosis or other ...).
Exclusion
Key Trial Info
Start Date :
March 15 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 21 2021
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04829812
Start Date
March 15 2021
End Date
December 21 2021
Last Update
January 12 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uhmontpellier
Montpellier, France, 34295